Gerson Research Organization
Hildenbrand LC. Nutritional Immunotherapy Home Guide. The official patient guidebook of the GRO/CHIPSA immunotherapy program. Gerson Research Organization, November, 2011; San Diego, CA.
Hildenbrand GLG. Practice of Gerson's diet therapy in neoplastic diseases: A tissue-centric nutritional immunotherapy that anticipated Matzinger's Danger Model with its tissue-based effector class control. Lecture and PowerPoint presentation to the American Academy of Anti-Aging Medicine Fellowship in Integrative Cancer Therapy: Module II; June 25, 2011; Las Vegas, NV.
Hildenbrand GLG. A medical application of Matzinger's Danger Model: Coley's cancer vaccine. Lecture and PowerPoint presentation to the American Academy of Anti-Aging Medicine Fellowship in Integrative Cancer Therapy: Module V; August 14, 2010; Boca Raton, FL.
Hildenbrand GLG. The first century of Gerson's dietotherapy: From salt-and-water managment to immunotherapy. Lecture and PowerPoint presentation to the American Academy of Anti-Aging Medicine Fellowship in Integrative Cancer Therapy: Module V; May 20, 2010; Boca Raton, FL.
Hildenbrand GLG. A review of techniques used in an epidemiological retrospective evaluation of Gerson's cancer therapy. Paper presented by Gar Hildenbrand at the Practice Outcomes Monitoring and Evaluation System (POMES) Conference for Integrated Complementary and Alternative Medicine Cancer Practices, sponsored by National Institutes of Health Office of Alternative Medicine (NIH-OAM) and the National Cancer Institute (NCI), Bethesda, Maryland, August 4, 1997.
Hildenbrand GLG. Nutritional superiority of organically grown foods. Healing Newsletter 1989;5(2):
Gerson M. The cure of advanced cancer by diet therapy: a summary of 30 years of clinical experimentation. Physiol Chem Phys 1978;10(5):449-464
Updated the Treatment page.
Audio recordings of two lectures by Gar Hildenbrand are now online.
Cope FW. Mitochondrial disease in man: report of a probable case with successful therapy. Physiol Chem Phys 1981;13:275
Office of Technology Assessment. Unconventional Cancer Managements - Advisory Panel Meeting transcript. [source unkown] 1990-03-20
Hildenbrand GLG. Systemic lupus erythematosus: one disease, a thousand faces, a potent management. Healing Journal 1992;8(1-2):
An overview of the web site.
Ling GN. A Physical Theory of the Living State: the Association-Induction Hypothesis. New York, London; Blaisdell Publishing Company, A Division of Random House, Inc.; 1962
Ling GN. In Search of the Physical Basis of Life. New York and London; Plenum Press; 1984
Ling GN. A Revolution in the Physiology of the Living Cell. Malabar, Florida; Krieger Publishing Company; 1992
Ward PS. History of the Gerson therapy. Contract report prepared for the U.S. Office of Technology Assessment. U.S. Government Printing Office, 1988
Moss R. The Cancer Industry: The Classic Expose on the Cancer Establishment Equinox Press; 1996
Office of Technology Assessment. Unconventional Cancer Managements. U.S. Government Printing Office; OTA-H-405:1990.
Gerson M, Hildenbrand GLG (Editor). A Cancer Therapy, Results of Fifty Cases. 4th and 5th editions. San Diego, CA, Gerson Institute, 1986, 1990.
Haught J, Hildenbrand GLG, (Editor). Censured for curing cancer: the American experience of Dr. Max Gerson. 2nd edition. San Diego, CA, Gerson Institute, 1991.
Sauerbruch F. Master Surgeon (a.k.a. A Surgeon's Life) [Das War Mein Leben.] London, Andre Deutsch, 1953 [Muenchen ,Kindler, 1951]
Web site created.
Nine documents so far.